These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 791479)

  • 1. Yeast mutants with distorted cell membranes as tests in the screening for antitumor antibiotics.
    Gause GF; Laiko AV; Selesneva TI
    Cancer Treat Rep; 1976 May; 60(5):637-8. PubMed ID: 791479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utilization of yeast mutants with a defect in the cellular membrane in the search for anticancer antibiotics].
    Gauze GF; Laĭko AV; Selezneva TI
    Antibiotiki; 1976 Jul; 21(7):591-3. PubMed ID: 782350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast mutants with distorted cell membranes as a detection system for antitumor antibiotics.
    Gause GF; Laiko AV
    Antibiot Chemother (1971); 1978; 23():21-5. PubMed ID: 348079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antineoplastic agents on non proliferating yeast cells: a possible membrane effect of doxorubicin.
    Karavokyros I; Delitheos A
    Anticancer Res; 1997; 17(2A):1079-82. PubMed ID: 9137452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiometric prescreen for antitumor activity with Saccharomyces cerevisiae mutant strain.
    Speedie MK; Fique DV; Blomster RN
    Antimicrob Agents Chemother; 1980 Jul; 18(1):171-5. PubMed ID: 6998375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of DNA repair operating in yeast treated with the pyrrolo(1,4)-benzodiazepine antitumor antibiotics.
    Hannan MA; Hurley LH
    J Antibiot (Tokyo); 1978 Sep; 31(9):911-3. PubMed ID: 361666
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of petite mutants in yeast Saccharomyces cerevisiae by the anticancer drug dequalinium.
    Schneider-Berlin KR; Bonilla TD; Rowe TC
    Mutat Res; 2005 May; 572(1-2):84-97. PubMed ID: 15790492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered drug sensitivities to anticancer agents in radiation-sensitive DNA repair deficient yeast mutants.
    Abe H; Wada M; Kohno K; Kuwano M
    Anticancer Res; 1994; 14(5A):1807-10. PubMed ID: 7531413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCA1064-B, a new antitumor antibiotic isolated from Wallemia sebi: production, isolation and structural determination.
    Takahashi I; Maruta R; Ando K; Yoshida M; Iwasaki T; Kanazawa J; Okabe M; Tamaoki T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1312-4. PubMed ID: 8407596
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of polysaccharide TC-13 extracted from rare actinomycetes.
    Kohno M; Abe S; Sato K; Yamazaki M; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):1-9. PubMed ID: 6876473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of new N-substituted daunorubicin derivatives.
    Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
    Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analogues.
    Binaschi M; Farinosi R; Austin CA; Fisher LM; Zunino F; Capranico G
    Cancer Res; 1998 May; 58(9):1886-92. PubMed ID: 9581829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Saccharomyces cerevisiae: an efficient tool and model system for anticancer research].
    Kurtz JE; Dufour P; Duclos B; Bergerat JP; Exinger F
    Bull Cancer; 2004 Feb; 91(2):133-9. PubMed ID: 15047453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Staphylococcus aureus mutants in the search for antineoplastic antibiotics of Actinomycetes origin].
    Kochetkova GV; Il'chenko GB; Kovsharova IN; Rossolimo OK; Proshliakova VV
    Antibiotiki; 1969 Oct; 14(10):900-3. PubMed ID: 5355860
    [No Abstract]   [Full Text] [Related]  

  • 15. [Yeast resistance to polyene antibiotics. II. An analysis of the sterol composition of Saccharomyces cerevisiae yeasts resistant to nystatin].
    Levchenko AB; Rodina LV; Mikhaĭlova NP; Shabunov BE; Moseĭchuk AV
    Genetika; 1984 Jul; 20(7):1088-93. PubMed ID: 6381227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the D7 strain of S. cerevisiae in the determination of environmental genetic risk. 2. Genetic effects of procarbazine].
    Bronzetti G; Corsi C; Nieri R
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1322-8. PubMed ID: 7006635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yeast resistance to polyene antibiotics. III. Phenotypic analysis of polyene-resistant sterol mutants of Saccharomyces cerevisiae yeasts].
    Rodina LV; Levchenko AB; Mikhaĭlova NP
    Genetika; 1984 Jul; 20(7):1094-8. PubMed ID: 6381228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell fusion of Saccharomyces cerevisiae fragile mutants.
    Philipova DH; Venkov PV
    Yeast; 1990; 6(3):205-12. PubMed ID: 2190431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the yeast Saccharomyces cerevisiae as a pre-screening approach for assessment of chemical-induced phototoxicity.
    Marrot L; Labarussiat A; Perez P; Meunier JR
    Toxicol In Vitro; 2006 Sep; 20(6):1040-50. PubMed ID: 16497474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes.
    Nakamura S; Omura S; Hamada M; Nishimura T; Yamaki H
    J Antibiot (Tokyo); 1967 Jul; 20(4):217-22. PubMed ID: 6072896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.